RE:RE:RE:RE:RE:RE:MIBCWe all get the eventual outcome in circa 2022 the health canada access to new drugs patient program. What is our pps in 2020? What is it worth. These long winded statements o ly prove tlt was nothing but a time share for those flippers who mock true longs with retirement plans........ so will this quarterly deliver us back to .60c pre agm tank job or are we stuck until october 2020
Quattro74 wrote: Well, for me the bet still is on the commercialization that will come after FDA Accelerated Approval. I continue to believe that that eventual outcome is between 1 and 2 years away, even accounting for a Covid 19 delay. Now that US IND is approved to start, those US patients will just add to the story. So IF TLT demonstrates a high % CR on the first 25, be they Canadian, US, or a mix, still seems like a good ROI is possible. This is particularly true now that Roswell Park is doing their independent phase 1 using 1433. That is why I continue to post optimistically. :-) And, probably why G1 is still buying....
Hempdoc wrote:
goldn1 wrote:
come on guyss, part of the problem for all of this frustration is vector saying the metals patents itself are worth "billions", then quattro sayin if we get this or that NR tlt is worth at least 1 dollar... I have been around along time, long enough to see that all of these same posters, other, including Roger have predicted these multi dollar valuations... hey, I would love to see tlt worth 100 dollars, but these patents have proved nothing, so there worth nothing. To say the negativity of stockhouse posts contribute to the price is delusional, any NR will offer whatever is said on Stackhouse, plus most of us are buying at these levels, including myself for some reason. I guess I am in so deep might as well lose more.time for the company to show its " got the goods", posting on here is only about if, what and maybe this or that... smh
Hi goldn1...I think some of the added excitement is justified when such a reputable Cancer/PDT center of excellence (especially for lung CA) sees enough promise in your compound that they are willing to assume risk/resources to test it in a different indication (not at our expense). These experts know a good compound when they see it...& they see it as a legitimately promising cancer treatment & a likely replacement for Photofrin....this speaks volumes about the potential of our intellectually protected metals/ACT technology. Good luck...